Cambridge Healthtech’s 2nd Annual

CHINA: Clinical Development Partnering

Forging win-win relationships

March 2-3, 2021

 

The China Clinical Development Partnering conference at SCOPE provides a focused forum where Global and Chinese-based pharmaceutical companies, biotech companies, academic research centers, CROs, consultancies and other service providers involved in the conduct of drug development and clinical trials can share best practices for developing and bringing new therapies to market here in the West and in China. The stakeholders may be US or European sponsors interested in partnering with up-and-coming Chinese biotech companies, or they may be Chinese innovators looking for US-based CROs or licensing partners to expand their market and reach. This is not simply about “outsourcing”! This is about research-based innovators on both sides trying to figure out a win-win and trying to help one another navigate a two-way partnership. The forum will feature case studies, “how to” panel discussions, and networking. The atmosphere will be casual and interactive, though the topic is very important and somewhat complicated at this moment in time. Speaking proposals and panel proposals are being accepted, but they must include actual best practices and leaders who can offer accurate advice on how best to find partners on both sides. Topics to be discussed:

 

  • Forging Ahead in Unprecedented Times – Challenges in Conducting Drug Development and Clinical Trials in China
  • Impact of COVID-19 Pandemic on Clinical Research in China
  • Navigating the Chinese Regulatory Environment – GCP Requirements, INDs, BLAs and NDAs Development
  • China vs US Regulatory Environment and Pathways
  • Joint Ventures, M&As or Licensing? Pros and Cons
  • China’s Innovative Biotechs Spotlight – Where are the key growth areas in China’s biotech industry?
  • Partnering with Chinese Biotechs and CROs – Understanding and Finding the Right CROs in US or China
  • Establishing a US-China Alliance for Drug Development and Market Access
  • Developing a Clinical Trial Strategy for China
  • Patient Recruitment and Data Monitoring
  • Conducting COVID-19 Clinical Trials in China

     

 

If you would like to submit a proposal to give a presentation at this meeting, please contact:
Mimi Langley 郭咪咪
mlangley@healthtech.com
wechat ID: quek_mimi

 

For more details on the conference, please contact: Mimi Langley 郭咪咪

Senior Director, Conferences

Cambridge Healthtech Institute (CHI)

Phone: (+1) 781-972-5439

Email: mlangley@healthtech.com

 

For partnering and sponsorship information, please contact:

Companies A-O

Ilana Quigley

Senior Manager, Business Development

Cambridge Healthtech Institute (CHI)

Phone: (+1) 781.972.5457

Email: iquigley@healthtech.com

 

Companies P-Z

Patty Rose Senior Manager, Business Development

Cambridge Healthtech Institute (CHI)

Phone: (+1) 781.972.1349

Email: prose@healthtech.com

 

Group Discounts Are Available! For information, contact:

Melissa Dolen

Phone: (+1) 781-972-5418

Email: mdolen@healthtech.com